Real world data of ixazomib in combination with lenalidomide and dexamethasome
A multiple myeloma patient story - a discussion between Vivien de Gunzburg and Paul Richardson
Paul Richardson et al.
Upcoming amyloidosis clinical trial data to look forward to at ASH 2017
Dr Moorman's highlights on mixed phenotype acute leukemia (MPAL) from ASH 2016
Bendamustine plus rituximab vs. standard therapy for advanced CLL